14:00 - 15:15
ET
Webcast
Advancing immunotherapy for blood cancers - Innovation in research
Join Dr. Natasha Kekre, hematologist at The Ottawa Hospital and researcher, as she explores the latest advances in immunotherapy for blood cancers, including:
- The evolution and impact of CAR-T cell therapy and bispecific antibodies
- Emerging trends and future directions in immunotherapy for leukemia, lymphoma, multiple myeloma, and other blood cancers
Dr. Kekre leads BioCanRx’s Canadian-led Immunotherapies in Cancer (CLIC-01) trial, for which LLSC is a funding partner. This webcast is brought to you by LLSC in partnership with BioCanRX, Canada's immunotherapy network.
Note: This webcast may be more complex than our usual webcasts - making it ideal for audiences with an interest in advanced research and technologies applied to medical science.
Dr. Natasha Kekre
Dr. Natasha Kekre is a hematologist in the transplant and cellular therapy program at The Ottawa Hospital, and a scientist at the Ottawa Hospital Research Institute.
This event is in partnership with:
